Published in Neuropsychopharmacology on June 30, 2010
Fear conditioning, synaptic plasticity and the amygdala: implications for posttraumatic stress disorder. Trends Neurosci (2011) 2.12
Altered fear learning across development in both mouse and human. Proc Natl Acad Sci U S A (2012) 1.77
Rewards, aversions and affect in adolescence: emerging convergences across laboratory animal and human data. Dev Cogn Neurosci (2011) 1.61
The study of fear extinction: implications for anxiety disorders. Am J Psychiatry (2011) 1.60
Selective early-acquired fear memories undergo temporary suppression during adolescence. Proc Natl Acad Sci U S A (2011) 1.23
NMDA receptors and fear extinction: implications for cognitive behavioral therapy. Dialogues Clin Neurosci (2011) 1.17
Individual differences in recovery from traumatic fear. Trends Neurosci (2012) 1.10
Cognitive enhancers for anxiety disorders. Pharmacol Biochem Behav (2010) 1.04
Treating the Developing versus Developed Brain: Translating Preclinical Mouse and Human Studies. Neuron (2015) 1.01
Fear extinction induces mGluR5-mediated synaptic and intrinsic plasticity in infralimbic neurons. J Neurosci (2013) 1.01
Pharmacological enhancement of fear reduction: preclinical models. Br J Pharmacol (2011) 0.99
Failure of neural responses to safety cues in schizophrenia. Arch Gen Psychiatry (2012) 0.99
Stress and Fear Extinction. Neuropsychopharmacology (2015) 0.98
Fear and anxiety from principle to practice: implications for when to treat youth with anxiety disorders. Biol Psychiatry (2013) 0.97
Fear conditioning and extinction across development: evidence from human studies and animal models. Biol Psychol (2014) 0.96
Adolescent C57BL/6J mice show elevated alcohol intake, but reduced taste aversion, as compared to adult mice: a potential behavioral mechanism for binge drinking. Alcohol Clin Exp Res (2011) 0.95
New perspectives on adolescent motivated behavior: attention and conditioning. Dev Cogn Neurosci (2011) 0.91
D-cycloserine in Schizophrenia: New Strategies for Improving Clinical Outcomes by Enhancing Plasticity. Curr Neuropharmacol (2017) 0.90
Effects of pharmacological manipulations of NMDA-receptors on deliberation in the Multiple-T task. Neurobiol Learn Mem (2011) 0.89
The Neuro-Environmental Loop of Plasticity: A Cross-Species Analysis of Parental Effects on Emotion Circuitry Development Following Typical and Adverse Caregiving. Neuropsychopharmacology (2015) 0.86
Mechanisms to medicines: elucidating neural and molecular substrates of fear extinction to identify novel treatments for anxiety disorders. Br J Pharmacol (2014) 0.86
Transitional and translational studies of risk for anxiety. Depress Anxiety (2011) 0.86
Age differences in fear retention and extinction in male Sprague-Dawley rats: effects of ethanol challenge during conditioning. Behav Brain Res (2013) 0.84
Sensitive periods in affective development: nonlinear maturation of fear learning. Neuropsychopharmacology (2014) 0.84
Dynamic changes in neural circuitry during adolescence are associated with persistent attenuation of fear memories. Nat Commun (2016) 0.84
Treating the developing brain: implications from human imaging and mouse genetics. Annu Rev Med (2012) 0.83
Action selection performance of a reconfigurable basal ganglia inspired model with Hebbian-Bayesian Go-NoGo connectivity. Front Behav Neurosci (2012) 0.83
Developmental regulation of fear learning and anxiety behavior by endocannabinoids. Genes Brain Behav (2015) 0.82
Early experiences and the development of emotional learning systems in rats. Biol Mood Anxiety Disord (2013) 0.82
Translational developmental studies of stress on brain and behavior: implications for adolescent mental health and illness? Neuroscience (2013) 0.82
Common Polymorphisms in the Age of Research Domain Criteria (RDoC): Integration and Translation. Biol Psychiatry (2015) 0.82
Individual differences in frontolimbic circuitry and anxiety emerge with adolescent changes in endocannabinoid signaling across species. Proc Natl Acad Sci U S A (2016) 0.82
Fear learning and memory across adolescent development: Hormones and Behavior Special Issue: Puberty and Adolescence. Horm Behav (2013) 0.81
Sensitive periods in fear learning and memory. Stress (2013) 0.81
Risk for anxiety and implications for treatment: developmental, environmental, and genetic factors governing fear regulation. Ann N Y Acad Sci (2013) 0.80
Developmental rodent models of fear and anxiety: from neurobiology to pharmacology. Br J Pharmacol (2014) 0.80
Spontaneous recovery of fear reverses extinction-induced excitability of infralimbic neurons. PLoS One (2014) 0.79
Advances in the treatment of pediatric obsessive-compulsive d-cycloserine with exposure and response prevention. Neuropsychiatry (London) (2012) 0.79
The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain Development. Neuropsychopharmacology (2017) 0.78
Nonlinear developmental trajectory of fear learning and memory. Ann N Y Acad Sci (2013) 0.78
Easy to remember, difficult to forget: the development of fear regulation. Dev Cogn Neurosci (2014) 0.78
Post-retrieval extinction in adolescence prevents return of juvenile fear. Learn Mem (2016) 0.77
Extinction during memory reconsolidation blocks recovery of fear in adolescents. Sci Rep (2015) 0.77
The Impact of Developmental Timing for Stress and Recovery. Neurobiol Stress (2015) 0.77
Forming competing fear learning and extinction memories in adolescence makes fear difficult to inhibit. Learn Mem (2015) 0.77
Negative occasion setting in juvenile rats. Behav Processes (2016) 0.77
Optimizing treatments for anxiety by age and genetics. Ann N Y Acad Sci (2015) 0.76
Candesartan ameliorates impaired fear extinction induced by innate immune activation. Brain Behav Immun (2015) 0.76
"Altered Fear in Mice and Humans". Curr Dir Psychol Sci (2013) 0.76
Infralimbic EphB2 Modulates Fear Extinction in Adolescent Rats. J Neurosci (2015) 0.76
Emotional learning, stress, and development: An ever-changing landscape shaped by early-life experience. Neurobiol Learn Mem (2017) 0.75
The Role of BDNF in the Development of Fear Learning. Depress Anxiety (2016) 0.75
Cross-species approaches to cognitive neuroplasticity research. Neuroimage (2015) 0.75
Amygdala-Cortical Connectivity: Associations with Anxiety, Development, and Threat. Depress Anxiety (2016) 0.75
The transition from childhood to adolescence is marked by a general decrease in amygdala reactivity and an affect-specific ventral-to-dorsal shift in medial prefrontal recruitment. Dev Cogn Neurosci (2016) 0.75
Age differences in appetitive Pavlovian conditioning and extinction in rats. Physiol Behav (2016) 0.75
PI3-kinase cascade has a differential role in acquisition and extinction of conditioned fear memory in juvenile and adult rats. Learn Mem (2016) 0.75
Prefrontal Dopaminergic Mechanisms of Extinction in Adolescence Compared to Adulthood in Rats. Front Behav Neurosci (2017) 0.75
Aripiprazole Facilitates Extinction of Conditioned Fear in Adolescent Rats. Front Behav Neurosci (2017) 0.75
Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry (2005) 58.92
Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci U S A (2004) 17.86
Extinction learning in humans: role of the amygdala and vmPFC. Neuron (2004) 8.63
Neurons in medial prefrontal cortex signal memory for fear extinction. Nature (2002) 8.43
Neurodevelopmental trajectories of the human cerebral cortex. J Neurosci (2008) 7.14
Structural magnetic resonance imaging of the adolescent brain. Ann N Y Acad Sci (2004) 6.13
Recall of fear extinction in humans activates the ventromedial prefrontal cortex and hippocampus in concert. Biol Psychiatry (2007) 5.56
In vivo evidence for post-adolescent brain maturation in frontal and striatal regions. Nat Neurosci (1999) 5.34
Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry (2004) 5.26
The role of ventromedial prefrontal cortex in the recovery of extinguished fear. J Neurosci (2000) 4.79
Behavioral and neural analysis of extinction. Neuron (2002) 4.53
Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats. J Neurosci (2002) 4.52
Development of the adolescent brain: implications for executive function and social cognition. J Child Psychol Psychiatry (2006) 4.39
Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder. Am J Psychiatry (2008) 3.63
Effects of D-cycloserine on extinction: translation from preclinical to clinical work. Biol Psychiatry (2006) 3.45
Extinction of fear-potentiated startle: blockade by infusion of an NMDA antagonist into the amygdala. J Neurosci (1992) 3.40
Consolidation of fear extinction requires NMDA receptor-dependent bursting in the ventromedial prefrontal cortex. Neuron (2007) 3.32
Thickness of ventromedial prefrontal cortex in humans is correlated with extinction memory. Proc Natl Acad Sci U S A (2005) 2.78
Augmentation of exposure therapy with D-cycloserine for social anxiety disorder. Arch Gen Psychiatry (2006) 2.77
Fear conditioning and extinction differentially modify the intrinsic excitability of infralimbic neurons. J Neurosci (2008) 2.77
Distribution of N-methyl-D-aspartate-sensitive L-[3H]glutamate-binding sites in rat brain. J Neurosci (1985) 2.66
Memory for extinction of conditioned fear is long-lasting and persists following spontaneous recovery. Learn Mem (2002) 2.57
Effects of D-cycloserine on extinction of conditioned freezing. Behav Neurosci (2003) 2.39
A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy. Biol Psychiatry (2008) 2.17
Delayed recall of fear extinction in rats with lesions of ventral medial prefrontal cortex. Learn Mem (2004) 2.09
A randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder. Biol Psychiatry (2008) 2.03
Cognitive processes during fear acquisition and extinction in animals and humans: implications for exposure therapy of anxiety disorders. Clin Psychol Rev (2007) 1.93
Gender differences in anxiety disorders and anxiety symptoms in adolescents. J Abnorm Psychol (1998) 1.90
D-cycloserine and the facilitation of extinction of conditioned fear: consequences for reinstatement. Behav Neurosci (2004) 1.75
Synapse elimination and plasticity in developing human cerebral cortex. Am J Ment Defic (1984) 1.63
D-cycloserine facilitates extinction of learned fear: effects on reacquisition and generalized extinction. Biol Psychiatry (2005) 1.53
Social cognitive development during adolescence. Soc Cogn Affect Neurosci (2006) 1.46
D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder. Int Clin Psychopharmacol (2007) 1.46
Postextinction infusion of a mitogen-activated protein kinase inhibitor into the medial prefrontal cortex impairs memory of the extinction of conditioned fear. Learn Mem (2004) 1.42
New findings on extinction of conditioned fear early in development: theoretical and clinical implications. Biol Psychiatry (2009) 1.40
Ontogeny of fear-, anxiety- and depression-related behavior across adolescence in C57BL/6J mice. Behav Brain Res (2006) 1.37
The NMDA antagonist MK-801 blocks the extinction of Pavlovian fear conditioning. Behav Neurosci (1996) 1.33
Fear extinction across development: the involvement of the medial prefrontal cortex as assessed by temporary inactivation and immunohistochemistry. J Neurosci (2009) 1.32
D-cycloserine facilitates context-specific fear extinction learning. Neurobiol Learn Mem (2008) 1.28
Neuronal development in human prefrontal cortex in prenatal and postnatal stages. Prog Brain Res (1990) 1.16
Immunohistochemical analyses of long-term extinction of conditioned fear in adolescent rats. Cereb Cortex (2010) 1.15
Mood variability and the psychosocial adjustment of adolescents. J Youth Adolesc (1980) 1.15
A developmental dissociation in reinstatement of an extinguished fear response in rats. Neurobiol Learn Mem (2007) 1.11
A developmental dissociation of context and GABA effects on extinguished fear in rats. Behav Neurosci (2007) 1.11
The development of the rat prefrontal cortex. Its size and development of connections with thalamus, spinal cord and other cortical areas. Prog Brain Res (1990) 1.08
Extinction in the developing rat: an examination of renewal effects. Dev Psychobiol (2007) 1.01
D-cycloserine facilitates extinction the first time but not the second time: an examination of the role of NMDA across the course of repeated extinction sessions. Neuropsychopharmacology (2008) 1.01
Influence of ethanol withdrawal on fear memory: Effect of D-cycloserine. Neuroscience (2006) 1.00
The effect of the NMDA receptor antagonist MK-801 on the acquisition and extinction of learned fear in the developing rat. Learn Mem (2007) 0.93
Behavioral and paired-pulse facilitation analyses of long-lasting depression at excitatory synapses in the medial prefrontal cortex in mice. Behav Brain Res (2003) 0.92
An fMRI study examining effects of acute D-cycloserine during symptom provocation in spider phobia. CNS Spectr (2009) 0.81
Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol (2010) 5.51
Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib. J Clin Oncol (2005) 4.03
Intratumoral heterogeneity of HER2 gene amplification in breast cancer: its clinicopathological significance. Mod Pathol (2012) 4.00
Effects of D-cycloserine on extinction: translation from preclinical to clinical work. Biol Psychiatry (2006) 3.45
Effects of D-cycloserine on extinction of conditioned freezing. Behav Neurosci (2003) 2.39
A randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder. Biol Psychiatry (2008) 2.03
Survival benefit of gastrectomy ± metastasectomy in patients with metastatic gastric cancer receiving chemotherapy. Gastric Cancer (2011) 1.98
S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for first-line treatment of patients with metastatic colorectal cancer: a randomised, non-inferiority phase 3 trial. Lancet Oncol (2012) 1.98
Hippocampal and prefrontal projections to the basal amygdala mediate contextual regulation of fear after extinction. J Neurosci (2011) 1.77
D-cycloserine and the facilitation of extinction of conditioned fear: consequences for reinstatement. Behav Neurosci (2004) 1.75
Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis. Breast Cancer Res (2011) 1.69
Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer. BMC Cancer (2007) 1.68
Acute systemic fibroblast growth factor-2 enhances long-term extinction of fear and reduces reinstatement in rats. Neuropsychopharmacology (2009) 1.58
D-cycloserine facilitates extinction of learned fear: effects on reacquisition and generalized extinction. Biol Psychiatry (2005) 1.53
Optimization of patient selection for gefitinib in non-small cell lung cancer by combined analysis of epidermal growth factor receptor mutation, K-ras mutation, and Akt phosphorylation. Clin Cancer Res (2006) 1.53
Effects of multiple exposures to D-cycloserine on extinction of conditioned fear in rats. Neurobiol Learn Mem (2005) 1.52
A randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear. J Psychiatr Res (2006) 1.44
A randomized controlled trial of the effect of D-cycloserine on extinction and fear conditioning in humans. Behav Res Ther (2006) 1.44
New findings on extinction of conditioned fear early in development: theoretical and clinical implications. Biol Psychiatry (2009) 1.40
The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer. BMC Cancer (2008) 1.38
Promoter CpG island hypermethylation during breast cancer progression. Virchows Arch (2010) 1.34
Erasing fear memories with extinction training. J Neurosci (2010) 1.33
Reinstatement of fear to an extinguished conditioned stimulus: two roles for context. J Exp Psychol Anim Behav Process (2002) 1.32
Fear extinction across development: the involvement of the medial prefrontal cortex as assessed by temporary inactivation and immunohistochemistry. J Neurosci (2009) 1.32
Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer. BMC Cancer (2012) 1.31
Effects of D-cycloserine on extinction of learned fear to an olfactory cue. Neurobiol Learn Mem (2007) 1.28
Cerebral perfusion changes in mesial temporal lobe epilepsy: SPM analysis of ictal and interictal SPECT. Neuroimage (2005) 1.25
Do-not-resuscitate orders for terminal patients with cancer in teaching hospitals of Korea. J Palliat Med (2007) 1.25
The growth inhibitory effect of lapatinib, a dual inhibitor of EGFR and HER2 tyrosine kinase, in gastric cancer cell lines. Cancer Lett (2008) 1.23
Clinical outcomes of leptomeningeal metastasis in patients with non-small cell lung cancer in the modern chemotherapy era. Lung Cancer (2011) 1.22
The effect of temporary amygdala inactivation on extinction and reextinction of fear in the developing rat: unlearning as a potential mechanism for extinction early in development. J Neurosci (2008) 1.21
Immunohistochemical analyses of long-term extinction of conditioned fear in adolescent rats. Cereb Cortex (2010) 1.15
A developmental dissociation in reinstatement of an extinguished fear response in rats. Neurobiol Learn Mem (2007) 1.11
A developmental dissociation of context and GABA effects on extinguished fear in rats. Behav Neurosci (2007) 1.11
Modified FOLFOX-6 chemotherapy in advanced gastric cancer: Results of phase II study and comprehensive analysis of polymorphisms as a predictive and prognostic marker. BMC Cancer (2008) 1.11
Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment. J Neurooncol (2011) 1.11
Efficacy and toxicity of pemetrexed as a third-line treatment for non-small cell lung cancer. Jpn J Clin Oncol (2008) 1.10
Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy. Breast Cancer Res Treat (2008) 1.09
Maternal separation results in early emergence of adult-like fear and extinction learning in infant rats. Behav Neurosci (2011) 1.03
Extinction in the developing rat: an examination of renewal effects. Dev Psychobiol (2007) 1.01
From resilience to vulnerability: mechanistic insights into the effects of stress on transitions in critical period plasticity. Front Psychiatry (2013) 1.01
D-cycloserine facilitates extinction the first time but not the second time: an examination of the role of NMDA across the course of repeated extinction sessions. Neuropsychopharmacology (2008) 1.01
Temozolomide for malignant primary spinal cord glioma: an experience of six cases and a literature review. J Neurooncol (2010) 1.00
Fibroblast growth factor-2 enhances extinction and reduces renewal of conditioned fear. Neuropsychopharmacology (2010) 1.00
Pharmacological enhancement of fear reduction: preclinical models. Br J Pharmacol (2011) 0.99
Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent chemoradiotherapy with capecitabine for locally advanced pancreatic cancer. Cancer Chemother Pharmacol (2012) 0.99
A survey of sleep deprivation patterns and their effects on cognitive functions of residents and interns in Korea. Sleep Med (2011) 0.98
Task positive and default mode networks during a parametric working memory task in obstructive sleep apnea patients and healthy controls. Sleep (2011) 0.98
The role of carcinoembryonic antigen after neoadjuvant chemoradiotherapy in patients with rectal cancer. Dis Colon Rectum (2011) 0.98
Cerebral perfusion abnormality in narcolepsy with cataplexy. Neuroimage (2005) 0.97
Glucose hypometabolism of hypothalamus and thalamus in narcolepsy. Ann Neurol (2004) 0.97
Preoperative chemoradiation with cetuximab, irinotecan, and capecitabine in patients with locally advanced resectable rectal cancer: a multicenter Phase II study. Int J Radiat Oncol Biol Phys (2010) 0.96
Weight changes after adjuvant treatment in Korean women with early breast cancer. Breast Cancer Res Treat (2008) 0.96
Potential prognostic value of heat-shock protein 90 in the presence of phosphatidylinositol-3-kinase overexpression or loss of PTEN, in invasive breast cancers. Breast Cancer Res (2010) 0.96
Pharmacological dissociation of trace and long-delay fear conditioning in young rats. Neurobiol Learn Mem (2006) 0.95
Memory retrieval before or after extinction reduces recovery of fear in adolescent rats. Learn Mem (2013) 0.95
Nomogram predicting clinical outcomes in breast cancer patients treated with neoadjuvant chemotherapy. J Cancer Res Clin Oncol (2011) 0.95
Effects of D-cycloserine on extinction: consequences of prior exposure to imipramine. Biol Psychiatry (2007) 0.95
Different characteristics and prognostic impact of deep-vein thrombosis / pulmonary embolism and intraabdominal venous thrombosis in colorectal cancer patients. Thromb Haemost (2011) 0.95
A multicenter phase II study of gemcitabine and S-1 combination chemotherapy in patients with unresectable pancreatic cancer. Cancer Chemother Pharmacol (2009) 0.95
Pseudoprogression in patients with malignant gliomas treated with concurrent temozolomide and radiotherapy: potential role of p53. J Neurooncol (2010) 0.94
Effect of muscle mass on toxicity and survival in patients with colon cancer undergoing adjuvant chemotherapy. Support Care Cancer (2014) 0.94
Irinotecan combined with 5-fluorouracil and leucovorin as second-line chemotherapy for metastatic or relapsed gastric cancer. Jpn J Clin Oncol (2008) 0.93
Anemia and activities of daily living in the Korean urban elderly population: results from the Korean Longitudinal Study on Health and Aging (KLoSHA). Ann Hematol (2012) 0.93
The effect of the NMDA receptor antagonist MK-801 on the acquisition and extinction of learned fear in the developing rat. Learn Mem (2007) 0.93
Safety, compliance, and predictive parameters for dosage modification in adjuvant S-1 chemotherapy for gastric cancer. Cancer Sci (2012) 0.93
Distinct patterns of promoter CpG island methylation of breast cancer subtypes are associated with stem cell phenotypes. Mod Pathol (2011) 0.92
The early discontinuation of palliative chemotherapy in older patients with cancer. Support Care Cancer (2013) 0.91
Triple negativity and young age as prognostic factors in lymph node-negative invasive ductal carcinoma of 1 cm or less. BMC Cancer (2010) 0.91
Case of complete recovery of pancytopenia after treatment of hypopituitarism. Ann Hematol (2003) 0.91
KRAS mutation status and clinical outcome of preoperative chemoradiation with cetuximab in locally advanced rectal cancer: a pooled analysis of 2 phase II trials. Int J Radiat Oncol Biol Phys (2012) 0.91
Neoadjuvant etoposide, ifosfamide, and cisplatin for the treatment of olfactory neuroblastoma. Cancer (2004) 0.91
US habituation, like CS extinction, produces a decrement in conditioned fear responding that is NMDA dependent and subject to renewal and reinstatement. Neurobiol Learn Mem (2010) 0.91
Postoperative alteration of cerebral glucose metabolism in mesial temporal lobe epilepsy. Brain (2005) 0.90
Weekly paclitaxel and trastuzumab as a first-line therapy in patients with HER2-overexpressing metastatic breast cancer: magnitude of HER2/neu amplification as a predictive factor for efficacy. J Korean Med Sci (2009) 0.90
Transforming growth factor-beta1 induces apoptosis in vascular endothelial cells by activation of mitogen-activated protein kinase. Surgery (2002) 0.90
Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy. BMC Cancer (2011) 0.90
Pharmacogenetic analysis of adjuvant FOLFOX for Korean patients with colon cancer. Cancer Chemother Pharmacol (2013) 0.90
Recovery of fear memories in rats: role of gamma-amino butyric acid (GABA) in infantile amnesia. Behav Neurosci (2006) 0.89
Temporary inactivation of the nucleus accumbens disrupts acquisition and expression of fear-potentiated startle in rats. Brain Res (2004) 0.89
Fibroblast growth factor-2 alters the nature of extinction. Learn Mem (2011) 0.89
Venous thromboembolism in patients with pancreatic adenocarcinoma: lower incidence in Asian ethnicity. Thromb Res (2008) 0.89
The prognostic value of the nodal ratio in N1 breast cancer. Radiat Oncol (2011) 0.88
Early-life exposure to fibroblast growth factor-2 facilitates context-dependent long-term memory in developing rats. Behav Neurosci (2010) 0.88
Resection extent versus postoperative outcomes of seizure and memory in mesial temporal lobe epilepsy. Seizure (2005) 0.87
Differential involvement of the medial prefrontal cortex in the expression of learned fear across development. Behav Neurosci (2012) 0.87
Anaplastic thyroid carcinoma initially presented with abdominal cutaneous mass and hyperthyroidism. Korean J Intern Med (2010) 0.87
Role of cues and contexts on drug-seeking behaviour. Br J Pharmacol (2014) 0.87
ABCB1, FCGR2A, and FCGR3A polymorphisms in patients with HER2-positive metastatic breast cancer who were treated with first-line taxane plus trastuzumab chemotherapy. Oncology (2012) 0.86
Extinction in preweanling rats does not involve NMDA receptors. Neurobiol Learn Mem (2010) 0.86
Biomarker analysis in patients with advanced gastric cancer treated with S-1 plus cisplatin chemotherapy: orotate phosphoribosyltransferase expression is associated with treatment outcomes. Med Oncol (2010) 0.86
Phase II trial of low-dose paclitaxel and cisplatin in patients with advanced gastric cancer. Jpn J Clin Oncol (2005) 0.86
Irinotecan combined with 5-fluorouracil and leucovorin third-line chemotherapy after failure of fluoropyrimidine, platinum, and taxane in gastric cancer: treatment outcomes and a prognostic model to predict survival. Gastric Cancer (2012) 0.85
Who should be admitted to the intensive care unit? The outcome of intensive care unit admission in stage IIIB-IV lung cancer patients. Med Oncol (2014) 0.85
Intraamygdala infusion of fibroblast growth factor 2 enhances extinction and reduces renewal and reinstatement in adult rats. J Neurosci (2011) 0.85
Phosphorylation of mitogen-activated protein kinase in the medial prefrontal cortex and the amygdala following memory retrieval or forgetting in developing rats. Neurobiol Learn Mem (2011) 0.85
Metastatic adrenocortical carcinoma treated with sunitinib: a case report. Jpn J Clin Oncol (2009) 0.85